04 Feb 2016
/ Uni Research, Press releases
New Insights Into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors. Researchers at the Biozentrum of the University of Basel, in collaboration with scientists from the Paul Scherrer Institute, have now elucidated in detail how the structure of such a receptor changes when drugs bind and how the structural change transmits a signal to the cellular interior.
